Wegovy Tracker App
Track Your Wegovy Protocol
Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Wegovy protocol — doses, side effects, weight, and labs.
What Is Wegovy?
Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Wegovy protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Wegovy protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Wegovy protocol record from day one.
How to Track Your Wegovy Protocol
Wegovy Key Facts
Protocol FAQs
Clinical trials showed average weight loss of 15-20% of body weight. Many Shotlee users report similar or better results when tracking consistently.
Common side effects include nausea (especially during dose increases), vomiting, diarrhea, constipation, and fatigue. Shotlee helps you log these and identify patterns.
Yes! All core tracking features are free forever. Optional Pro features include AI insights and community access.
Open the Shotlee app, navigate to the dose logging screen, select Wegovy as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Wegovy Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semaglutide
Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.
8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.
8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.
6 min read